TGF β RI Antibodies

Santa Cruz Biotechnology features a diverse variety of TGF β RI monoclonal antibodies for research focused on understanding transforming growth factor beta receptor type I. TGF β RI Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).Transforming growth factor beta receptor type I mediates the effects of TGF-β, a key regulator of cell growth, differentiation, and immune response. TGF β RI plays a significant role in various biological processes, including tissue repair, fibrosis, and immune regulation, making it an important target for research in cancer, autoimmune diseases, and developmental biology. Understanding the signaling pathways involving TGF β RI can provide insights into therapeutic strategies for a range of diseases. Research has shown that TGF β RI signaling dysfunction contributes to numerous pathological conditions, from fibrotic disorders to cancer progression. Recent studies have highlighted the importance of TGF β RI in embryonic development and tissue homeostasis. Investigating TGF β RI expression patterns and activation mechanisms continues to reveal new potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TGF β RI biology and its therapeutic applications.